0 Commentarii
0 Distribuiri
4K Views
0 previzualizare
Căutare
Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni
-
Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
-
Can Targeting Endocrine Resistance Unlock New Breakthroughs in Cancer Treatment?Executive Summary Endocrine Resistance–Targeting Drug Market Size and Share Analysis Report CAGR Value The global endocrine resistance–targeting drug market size was valued at USD 2.96 billion in 2025 and is expected to reach USD 8.50 billion by 2033, at a CAGR of 14.10% during the forecast period This Endocrine...0 Commentarii 0 Distribuiri 701 Views 0 previzualizare
-
Crizotinib Drugs Market Growing at 6.7% CAGR Through 2034According to a new report from Intel Market Research, the global Crizotinib Drugs market was valued at USD 582.4 million in 2025 and is projected to reach USD 1,043.7 million by 2034, growing at a CAGR of 6.7% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of lung cancer, increasing adoption of molecular diagnostic testing for genetic...0 Commentarii 0 Distribuiri 117 Views 0 previzualizare
-
Epigenetics Market Graph: Growth, Share, Value, Insights, and Trends1. Introduction The Global Epigenetics Market has emerged as one of the most rapidly evolving sectors within the life sciences and biotechnology landscape. Epigenetics, the study of heritable changes in gene expression without alterations in the DNA sequence, is reshaping how researchers understand disease mechanisms, cellular functions, and the intricate regulation of human biology....0 Commentarii 0 Distribuiri 4K Views 0 previzualizare
-
Global Cabozantinib Drug Market Growing at 7.5% CAGR Through 2034According to a new report from Intel Market Research, the global Cabozantinib Drug market was valued at USD 2.12 billion in 2025 and is projected to reach USD 4.01 billion by 2034, growing at a robust CAGR of 7.5% during the forecast period (2026–2034). This growth is propelled by the escalating global burden of cancer, particularly renal and liver cancers, alongside expanding clinical...0 Commentarii 0 Distribuiri 184 Views 0 previzualizare
-
Is RNA-Based Therapy the Next Breakthrough in Cancer Treatment?Executive Summary RNA-Based Cancer Therapeutics Market Size and Share Across Top Segments CAGR Value The global RNA-based cancer therapeutics market size was valued at USD 415.8 million in 2025 and is expected to reach USD 947.1 million by 2033, at a CAGR of 10.80% during the forecast period Market drivers and market restraints covered in this...0 Commentarii 0 Distribuiri 456 Views 0 previzualizare
-
Is Synthetic Lethality the Future Breakthrough in Targeted Cancer Therapy?Executive Summary Synthetic Lethality Drug Market Size and Share Analysis Report CAGR Value The global Synthetic Lethality Drug market size was valued at USD 1.93 billion in 2025 and is expected to reach USD 8.07 billion by 2033, at a CAGR of 19.60% during the forecast period This Synthetic Lethality Drug Market research report guides the...0 Commentarii 0 Distribuiri 501 Views 0 previzualizare
-
TKIs for Breast Cancer Market Growing at 7.3% CAGR Through 2034According to a new report from Intel Market Research, the global TKIs for Breast Cancer market was valued at USD 1.82 billion in 2025 and is projected to reach USD 3.74 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2025–2034). This growth is propelled by the rising global incidence of breast cancer, growing adoption of precision oncology, and increasing regulatory...0 Commentarii 0 Distribuiri 124 Views 0 previzualizare
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Portuguese (Brazil)
Greek